• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中心体蛋白 55:肿瘤发生的新范例。

Centrosomal protein 55: A new paradigm in tumorigenesis.

机构信息

Molecular and Human Genetics Laboratory, Department of Zoology, University of Lucknow, Lucknow, Uttar Pradesh 226007, India.

Molecular and Human Genetics Laboratory, Department of Zoology, University of Lucknow, Lucknow, Uttar Pradesh 226007, India.

出版信息

Eur J Cell Biol. 2020 Jun;99(5):151086. doi: 10.1016/j.ejcb.2020.151086. Epub 2020 May 20.

DOI:10.1016/j.ejcb.2020.151086
PMID:32646645
Abstract

Centrosomal Protein 55 (Cep55), also known as c10orf3 and FLJ10540, was initially discovered as a major player in abscission, the final stage of cytokinesis. Subsequent studies have described its role in regulating the PI3K/AKT pathway, increasing cancer cell stemness, and promoting tumor formation. Clinically, Cep55 has been found to be overexpressed in many cancer types. Cep55 overexpression has been notably associated with tumor stage, tumor aggressiveness, poor prognosis, and metastasis. The present review discusses the role of Cep55 as a crucial biomarker and model in tumorigenesis.

摘要

中心体蛋白 55(Cep55),也称为 c10orf3 和 FLJ10540,最初被发现是胞质分裂末期(有丝分裂的最后阶段)的主要参与者。随后的研究描述了其在调节 PI3K/AKT 通路、增加癌细胞干性和促进肿瘤形成中的作用。临床上,已经发现 Cep55 在许多癌症类型中过度表达。Cep55 的过度表达与肿瘤分期、肿瘤侵袭性、不良预后和转移明显相关。本综述讨论了 Cep55 作为肿瘤发生的关键生物标志物和模型的作用。

相似文献

1
Centrosomal protein 55: A new paradigm in tumorigenesis.中心体蛋白 55:肿瘤发生的新范例。
Eur J Cell Biol. 2020 Jun;99(5):151086. doi: 10.1016/j.ejcb.2020.151086. Epub 2020 May 20.
2
Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis.超越胞质分裂:CEP55在肿瘤发生中的新作用。
Oncogene. 2016 Feb 11;35(6):683-90. doi: 10.1038/onc.2015.128. Epub 2015 Apr 27.
3
CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.CEP55 通过 PI3K/AKT/mTOR 通路促进肾细胞癌中的上皮-间充质转化。
Clin Transl Oncol. 2019 Jul;21(7):939-949. doi: 10.1007/s12094-018-02012-8. Epub 2019 Jan 3.
4
Cep55 overexpression promotes genomic instability and tumorigenesis in mice.CEP55 过表达促进小鼠的基因组不稳定性和肿瘤发生。
Commun Biol. 2020 Oct 21;3(1):593. doi: 10.1038/s42003-020-01304-6.
5
Centrosomal protein 55 activates NF-κB signalling and promotes pancreatic cancer cells aggressiveness.中心体蛋白 55 激活 NF-κB 信号通路并促进胰腺癌细胞的侵袭性。
Sci Rep. 2017 Jul 19;7(1):5925. doi: 10.1038/s41598-017-06132-z.
6
Cep55 overexpression causes male-specific sterility in mice by suppressing Foxo1 nuclear retention through sustained activation of PI3K/Akt signaling.CEP55 过表达通过持续激活 PI3K/Akt 信号抑制 Foxo1 核保留,导致小鼠雄性特异性不育。
FASEB J. 2018 Sep;32(9):4984-4999. doi: 10.1096/fj.201701096RR. Epub 2018 Apr 17.
7
Cep55/c10orf3, a tumor antigen derived from a centrosome residing protein in breast carcinoma.Cep55/c10orf3,一种源自乳腺癌中一种中心体驻留蛋白的肿瘤抗原。
J Immunother. 2009 Jun;32(5):474-85. doi: 10.1097/CJI.0b013e3181a1d109.
8
Integrin signaling via FAK-Src controls cytokinetic abscission by decelerating PLK1 degradation and subsequent recruitment of CEP55 at the midbody.通过黏着斑激酶-原癌基因酪氨酸蛋白激酶Src的整合素信号传导,通过减缓Polo样激酶1(PLK1)的降解以及随后在中体处募集细胞分裂周期蛋白55(CEP55)来控制细胞分裂后期的分裂。
Oncotarget. 2016 May 24;7(21):30820-30. doi: 10.18632/oncotarget.9003.
9
Cep55 promotes cytokinesis of neural progenitors but is dispensable for most mammalian cell divisions.Cep55 促进神经祖细胞的胞质分裂,但对于大多数哺乳动物细胞分裂是可有可无的。
Nat Commun. 2020 Apr 8;11(1):1746. doi: 10.1038/s41467-020-15359-w.
10
The peptidyl-prolyl isomerase Pin1 regulates cytokinesis through Cep55.肽基脯氨酰异构酶Pin1通过Cep55调节胞质分裂。
Cancer Res. 2009 Aug 15;69(16):6651-9. doi: 10.1158/0008-5472.CAN-09-0825. Epub 2009 Jul 28.

引用本文的文献

1
CEP55 Promotes Acral Melanoma Progression via MAPK Pathway and Predicts Survival Following Immunotherapy.CEP55通过MAPK途径促进肢端黑色素瘤进展并预测免疫治疗后的生存情况。
Oncol Res. 2025 Aug 28;33(9):2507-2527. doi: 10.32604/or.2025.064780. eCollection 2025.
2
Harnessing multi-omics and artificial intelligence: revolutionizing prognosis and treatment in hepatocellular carcinoma.利用多组学和人工智能:革新肝细胞癌的预后和治疗
Front Immunol. 2025 Jul 23;16:1592259. doi: 10.3389/fimmu.2025.1592259. eCollection 2025.
3
In-silico analysis of CEP55/E2F1/hsa-let-7b-5p/TMPO-AS1 axis-based ceRNA network promoting poor prognosis in lung adenocarcinoma smokers.
基于CEP55/E2F1/hsa-let-7b-5p/TMPO-AS1轴的ceRNA网络在肺腺癌吸烟者中促进预后不良的计算机模拟分析
Bioimpacts. 2025 Apr 16;15:30585. doi: 10.34172/bi.30585. eCollection 2025.
4
CEP55 as a prognostic indicator and a predictive marker in oral squamous cell carcinoma.CEP55作为口腔鳞状细胞癌的预后指标和预测标志物。
Int J Med Sci. 2025 Apr 28;22(10):2446-2459. doi: 10.7150/ijms.107996. eCollection 2025.
5
Pan-cancer analysis of oncogenic role of CEP55 and experiment validation in clear cell renal cell carcinoma.泛癌症分析 CEP55 的致癌作用及其在透明细胞肾细胞癌中的实验验证。
Sci Rep. 2024 Nov 16;14(1):28279. doi: 10.1038/s41598-024-80057-2.
6
ALKBH5 activates CEP55 transcription through m6A demethylation in FOXP2 mRNA and expedites cell cycle entry and EMT in ovarian cancer.ALKBH5 通过 FOXP2 mRNA 中的 m6A 去甲基化激活 CEP55 转录,从而促进卵巢癌细胞周期进入和 EMT。
Biol Direct. 2024 Nov 7;19(1):105. doi: 10.1186/s13062-024-00551-5.
7
Unveiling the significance of cancer-testis antigens and their implications for immunotherapy in glioma.揭示癌症睾丸抗原的重要性及其在神经胶质瘤免疫治疗中的意义。
Discov Oncol. 2024 Oct 29;15(1):602. doi: 10.1007/s12672-024-01449-4.
8
miR-378a-5p exerts tumor-suppressive effects on esophageal squamous cell carcinoma after neoadjuvant immunotherapy by downregulating APOC1/CEP55.miR-378a-5p 通过下调 APOC1/CEP55 对新辅助免疫治疗后的食管鳞癌发挥肿瘤抑制作用。
Sci Rep. 2024 Jan 3;14(1):305. doi: 10.1038/s41598-023-50938-z.
9
CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification.CEP55 作为一种有前途的免疫干预标志物,可调节肿瘤进展:基于实验验证的泛癌症分析。
Cells. 2023 Oct 15;12(20):2457. doi: 10.3390/cells12202457.
10
A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target.一项全面的泛癌分析将CEP55鉴定为一种潜在的癌基因和新型治疗靶点。
Diagnostics (Basel). 2023 May 2;13(9):1613. doi: 10.3390/diagnostics13091613.